
SGHT Valuation
Sight Sciences Inc
- Overview
- Forecast
- Valuation
- Earnings
SGHT Relative Valuation
SGHT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SGHT is overvalued; if below, it's undervalued.
Historical Valuation
Sight Sciences Inc (SGHT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.84 is considered Undervalued compared with the five-year average of -7.26. The fair price of Sight Sciences Inc (SGHT) is between 7.43 to 21.56 according to relative valuation methord. Compared to the current price of 4.23 USD , Sight Sciences Inc is Undervalued By 43.09%.
Relative Value
Fair Zone
7.43-21.56
Current Price:4.23
43.09%
Undervalued
-4.34
PE
1Y
3Y
5Y
Trailing
Forward
-4.55
EV/EBITDA
Sight Sciences Inc. (SGHT) has a current EV/EBITDA of -4.55. The 5-year average EV/EBITDA is -6.18. The thresholds are as follows: Strongly Undervalued below -19.71, Undervalued between -19.71 and -12.94, Fairly Valued between 0.59 and -12.94, Overvalued between 0.59 and 7.36, and Strongly Overvalued above 7.36. The current Forward EV/EBITDA of -4.55 falls within the Historic Trend Line -Fairly Valued range.
-3.21
EV/EBIT
Sight Sciences Inc. (SGHT) has a current EV/EBIT of -3.21. The 5-year average EV/EBIT is -5.35. The thresholds are as follows: Strongly Undervalued below -16.59, Undervalued between -16.59 and -10.97, Fairly Valued between 0.27 and -10.97, Overvalued between 0.27 and 5.89, and Strongly Overvalued above 5.89. The current Forward EV/EBIT of -3.21 falls within the Historic Trend Line -Fairly Valued range.
2.84
PS
Sight Sciences Inc. (SGHT) has a current PS of 2.84. The 5-year average PS is 6.09. The thresholds are as follows: Strongly Undervalued below -5.79, Undervalued between -5.79 and 0.15, Fairly Valued between 12.03 and 0.15, Overvalued between 12.03 and 17.97, and Strongly Overvalued above 17.97. The current Forward PS of 2.84 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Sight Sciences Inc. (SGHT) has a current P/OCF of 0.00. The 5-year average P/OCF is -3.09. The thresholds are as follows: Strongly Undervalued below -11.40, Undervalued between -11.40 and -7.25, Fairly Valued between 1.06 and -7.25, Overvalued between 1.06 and 5.21, and Strongly Overvalued above 5.21. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Sight Sciences Inc. (SGHT) has a current P/FCF of 0.00. The 5-year average P/FCF is -1.82. The thresholds are as follows: Strongly Undervalued below -7.74, Undervalued between -7.74 and -4.78, Fairly Valued between 1.14 and -4.78, Overvalued between 1.14 and 4.10, and Strongly Overvalued above 4.10. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Sight Sciences Inc (SGHT) has a current Price-to-Book (P/B) ratio of 3.13. Compared to its 3-year average P/B ratio of 2.40 , the current P/B ratio is approximately 30.40% higher. Relative to its 5-year average P/B ratio of 2.26, the current P/B ratio is about 38.34% higher. Sight Sciences Inc (SGHT) has a Forward Free Cash Flow (FCF) yield of approximately -10.22%. Compared to its 3-year average FCF yield of -18.50%, the current FCF yield is approximately -44.76% lower. Relative to its 5-year average FCF yield of -15.82% , the current FCF yield is about -35.40% lower.
3.13
P/B
Median3y
2.40
Median5y
2.26
-10.22
FCF Yield
Median3y
-18.50
Median5y
-15.82
Competitors Valuation Multiple
The average P/S ratio for SGHT's competitors is 21.21, providing a benchmark for relative valuation. Sight Sciences Inc Corp (SGHT) exhibits a P/S ratio of 2.84, which is -86.59% above the industry average. Given its robust revenue growth of -8.45%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of SGHT decreased by 37.52% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -57.69 to -61.04.
The secondary factor is the Revenue Growth, contributed -8.45%to the performance.
Overall, the performance of SGHT in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch

TDTH
Trident Digital Tech Holdings Ltd
0.700
USD
-0.99%

WHG
Westwood Holdings Group Inc
18.120
USD
-1.84%

HOFT
Hooker Furnishings Corp
10.175
USD
-0.25%

MPAA
Motorcar Parts of America Inc
14.890
USD
+2.41%

ALTO
Alto Ingredients Inc
1.050
USD
+0.96%

FRGE
Forge Global Holdings Inc
19.150
USD
-3.87%

INMB
INmune Bio Inc
2.160
USD
-3.57%

OPRT
Oportun Financial Corp
6.580
USD
+2.49%

VERU
Veru Inc
3.470
USD
-0.57%

VTYX
Ventyx Biosciences Inc
2.480
USD
-2.36%
FAQ

Is Sight Sciences Inc (SGHT) currently overvalued or undervalued?
Sight Sciences Inc (SGHT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.84 is considered Undervalued compared with the five-year average of -7.26. The fair price of Sight Sciences Inc (SGHT) is between 7.43 to 21.56 according to relative valuation methord. Compared to the current price of 4.23 USD , Sight Sciences Inc is Undervalued By 43.09% .

What is Sight Sciences Inc (SGHT) fair value?

How does SGHT's valuation metrics compare to the industry average?

What is the current P/B ratio for Sight Sciences Inc (SGHT) as of Aug 27 2025?

What is the current FCF Yield for Sight Sciences Inc (SGHT) as of Aug 27 2025?

What is the current Forward P/E ratio for Sight Sciences Inc (SGHT) as of Aug 27 2025?
